Aspirin as an adjunctive treatment for childhood onset schizophrenia

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 8, 2013, Pages 585-586

  Webb, Jadon E ^a   Stubbe, Dorothy E ^a   Poncin, Yann B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARIPIPRAZOLE;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADOLESCENT; BEHAVIOR DISORDER; BLUNTED AFFECT; CASE REPORT; CHILDHOOD DISEASE; CLINICAL FEATURE; DRUG DOSE TITRATION; FACIAL EXPRESSION; HALLUCINATION; HOSPITAL PATIENT; HUMAN; LETTER; MALE; MONOTHERAPY; NEGATIVE SYNDROME; ONSET AGE; PERSECUTORY DELUSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SPEECH;

ADOLESCENT; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPSYCHOTIC AGENTS; ASPIRIN; DRUG THERAPY, COMBINATION; HUMANS; MALE; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 84885999760     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0033     Document Type: Letter

References (8)

1. Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B: Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179-185, 2007.
2. Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G, Deakin B: Minocycline benefits negative symptoms in early schizophrenia: A randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 26:1185-1193, 2012.
3. Khandaker GM, Zimbron J, Lewis G, Jones PB: Prenatal maternal infection, neurodevelopment and adult schizophrenia: A systematic review of population-based studies. Psychol Med 43:239-257, 2013.
4. Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry, 65:146-152, 2008.
5. Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H: Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71:520-527, 2010.
6. Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Moller HJ, Klauss V, Schwarz MJ, Riedel M: Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res 121:118-124, 2010.
7. Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Moller HJ, Schwarz MJ: Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029-1034. 2002.
8. Nawa H, Yamada K: Experimental schizophrenia models in rodents established with inflammatory agents and cytokines. Methods Mol Biol 829:445-451, 2012.